Publications

Scientific publications

2023

  1. The relationship of hospital and surgeon volume indicators and post-operative outcomes in pancreatic surgery: a systematic literature review, meta-analysis and guidance for valid outcome assessment.
    Claudia Fischer, Stefanie J Alvarico, B Wildner, Martin Schindl, Judit Simon
    HPB Oxford, April 2023, doi: 10.1016/j.hpb.2023.01.008.
  2. Integrating weighted correlation network analysis and machine learning identifies common trajectories of prostate cancer.
    Raheleh Sheibani-Tezerji, Carlos Uziel Perez Malla, Anna Malzer, Katarina Misura, Jessica Kalla, Loan Tran, Gabriel Wasinger, Gerda Egger
    bioRxiv, March 2023, doi: https://doi.org/10.1101/2023.03.02.530740.
  3. Automated solid-phase synthesis of metabolically stabilized triazolo-peptidomimetics.
    Xabier Guarrochena, Barbara Kaudela, Thomas Mindt
    Journal of Peptide Science, March 2023, doi: 10.1002/psc.3488.
  4. Mimicking Tumor Cell Heterogeneity of Colorectal Cancer in a Patient-derived Organoid-Fibroblast Model.
    Velina S Atanasova, Crhistian de Jesus Cardona, Václav Hejret, Andreas Tiefenbacher, Theresia Mair, Loan Tran, Janette Pfneissl, Kristina Draganić, Carina Binder, Julijan Kabiljo, Janik Clement, Katharina Woeran, Barbara Neudert, Sabrina Wohlhaupter, Astrid Haase, Sandra Domazet, Markus Hengstschläger, Markus Mitterhauser, Leonhard Müllauer, Boris Tichý, Michael Bergmann, Gabriele Schweikert, Markus Hartl, Helmut Dolznig, Gerda Egger
    Cell Mol Gastroenterol Hepatol, March 2023, doi: 10.1016/j.jcmgh.2023.02.014.
  5. Sex-specific radiomic features of L-[S-methyl-11C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability.
    Laszlo Papp, Sazan Rasul, Clemens P Spielvogel, Denis Krajnc, Nina Poetsch, Adelheid Woehrer, Eva-Maria Patronas, Boglarka Ecsedi, Julia Furtner, Markus Mitterhauser, Ivo Rausch, Georg Widhalm, Thomas Beyer, Marcus Hacker, Tatjana Traub-Weidinger
    Front Oncol, February 2023, doi: 10.3389/fonc.2023.986788.
  6. Effects of bilateral sequential theta-burst stimulation on 5-HT1A receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial.
    Matej Murgaš, Jakob Unterholzner, Peter Stöhrmann, Cécile Philippe, Godber M Godbersen, Lukas Nics, Murray B Reed, Chrysoula Vraka, Thomas Vanicek, Wolfgang Wadsak, Georg S Kranz, Andreas Hahn, Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger, Pia Baldinger-Melich
    Transl Psychiatry, February 2023, doi: 10.1038/s41398-023-02319-3.
  7. Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA protein expression in primary hormone naïve prostate cancer.
    Valentin al Jalali, Gabriel Wasinger, Sazan Rasul, Bernhard Grubmueller, Beatrix Wulkersdorfer, Theresa Balber, Markus Mitterhauser, Judit Simon, Marcus Hacker, Sharokh Shariat, Gerda Egger, Markus Zeitlinger
    J Nucl Med, January 2023, doi: 10.2967/jnumed.122.264981.
  8. Comparison of Radiation Response between 2D and 3D Cell Culture Models of Different Human Cancer Cell Lines.
    Julia Raitanen, Bernadette Barta, Marcus Hacker, Dietmar Georg, Theresa Balber, Markus Mitterhauser
    Cells, January 2023, doi: 10.3390/cells12030360.
  9. Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood Levels.
    Valentin Al Jalali, Martin Bauer, Michael Wölfl-Duchek , Maysa Sarhan, Sebastian G Wicha, Stefan Poschner, Walter Jäger, Franz König, Christoph Male, Markus Zeitlinger
    Clin Pharmacokinet, January 2023, doi: 10.1007/s40262-022-01190-7.

2022

  1. Excess resource use and costs of physical comorbidities in individuals with mental health disorders: A systematic literature review and meta-analysis.
    Judit Simon, Dennis Wienand, A-La Park, Christoph Wippel, Susanne Mayer, Daniel Heilig, Agata Laszewska, Ines Stelzer, Guy M Goodwin, David McDaid
    Eur Neuropsychopharmacol, November 2022, doi: 10.1016/j.euroneuro.2022.10.001.
  2. CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging.
    Katarína Benčurová, Joachim Friske, Maximilian Anderla, Manuela Mayrhofer, Thomas Wanek, Lukas Nics, Gerda Egger, Thomas H Helbich, Marcus Hacker, Alexander Haug, Markus Mitterhauser, Theresa Balber
    Cancers (Basel), November 2022, doi: 10.3390/cancers14225549.
  3. Autoradiography on deparaffinized tissue sections – A feasibility study with 68Ga-labeled PET-tracers.
    Eva-Maria Klebermass, Anna Dengler, Victoria Weissenböck, Gerda Ricken, Wolfgang Wadsak, Helmut Viernstein, Marcus Hacker, Markus Mitterhauser, Cecile Philippe
    Appl Radiat Isot, November 2022, doi: 10.1016/j.apradiso.2022.110425.
  4. Response to [ 177 Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases.
    Lucia Zisser, Josef Yu, André Oszwald, Tim Wollenweber, Elisabeth Kretschmer-Chott, Bernhard Grubmüller, Gero Kramer, Shahrokh F Shariat, Markus Mitterhauser, Chrysoula Vraka, Marcus Hacker, Alexander R Haug, Sazan Rasul
    Nucl Med Commun, November 2022, doi: 10.1097/MNM.0000000000001611.
  5. Assessment of left and right ventricular functional parameters using dynamic dual-tracer [13N]NH3 and [18F]FDG PET/MRI.
    Sazan Rasul, Dietrich Beitzke, Tim Wollenweber, Ivo Rausch, Martin Lyngby Lassen, Marie Elisabeth Stelzmüller, Markus Mitterhauser, Verena Pichler, Thomas Beyer, Christian Loewe, Marcus Hacker
    J Nucl Cardiol, June 2022, doi: 10.1007/s12350-020-02391-y.
  6. PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma.
    Garces de los Fayos Alonso, L. Zujo, I. Wiest, P. Kodajova, G. Timelthaler, S. Edtmayer, M. Zrimšek, S. Kollmann, C. Giordano, M. Kothmayer, H. A. Neubauer, S. Dey, M. Schlederer, B. S. Schmalzbauer, T. Limberger, C. Probst, O. Pusch, S. Högler, S. Tangermann, O. Merkel, A. I. Schiefer, C. Kornauth, N. Prutsch, M. Zimmerman, B. Abraham, J. Anagnostopoulos, L. Quintanilla-Martinez, S. Mathas, P. Wolf, D. Stoiber, P. B. Staber, G. Egger, W. Klapper, W. Woessmann, T. A. Look, P. Gunning, S. D. Turner, R. Moriggl, S. Lagger, L. Kenner
    Mol Cancer, August 2022; doi: 10.1186/s12943-022-01640-7.
  7. Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma.
    Maša Zrimšek, Hana Kuchaříková, Kristina Draganić, Pavlína Dobrovolná, Verena Heiss Spornberger, Lisa Winkelmayer, Melanie R Hassler, Gabriela Lochmanová, Zbyněk Zdráhal, Gerda Egger
    Cells, August 2022, doi: 10.3390/cells11152380.
  8. EANM guideline on quality risk management for radiopharmaceuticals.
    Nic Gillings, Olaug Hjelstuen, Martin Behe, Clemens Decristoforo, Philip H Elsinga, Valentina Ferrari, Oliver C Kiss, Petra Kolenc, Jacek Koziorowski, Peter Laverman, Thomas L Mindt, Meltem Ocak, Marianne Patt, Sergio Todde, Almut Walte
    Eur J Nucl Med Mol Imaging, August 2022, doi: 10.1007/s00259-022-05738-4.
  9. Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1.
    Lucas Rischka, Matej Murgaš, Verena Pichler, Chrysoula Vraka, Ivo Rausch, Dietmar Winkler, Lukas Nics, Sazan Rasul, Leo Robert Silberbauer, Murray Bruce Reed, Godber Mathis Godbersen, Jakob Unterholzner, Patricia Handschuh, Gregor Gryglewski, Thomas Mindt, Markus Mitterhauser, Andreas Hahn, Simon Mensah Ametamey, Wolfgang Wadsak, Rupert Lanzenberger, Marcus Hacker
    EJNMMI Res, August 2022, https://doi: 10.1186/s13550-022-00925-8.
  10. Rapid, high-yield enzymatic synthesis of n.c.a. 6-[18F]fluorodopamine (6-[18F]FDA) for in vivo application.
    Karsten Bamminger, Julia Raitanen, Georgios Karanikas, Sazan Rasul, Lukas Nics, Markus Mitterhauser, Wolfgang Wadsak, Marcus Hacker, Verena Pichler, Chrysoula Vraka
    Nucl Med Biol, July 2022, https://doi: 10.1016/j.nucmedbio.2022.07.001.
  11. Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning.
    Attila Kiss, Ping Wu, Michaela Schlederer, Patrick M Pilz, Petra Lujza Szabo, Jingle Li, Lukas Weber, Chrysoula Vraka, Verena Pichler, Markus Mitterhauser, Xiaoli Zhang, Karin Zins, Dietmar Abraham, Sijin Li, Bruno K Podesser, Marcus Hacker, Xiang Li
    Basic Res Cardiol, August 2022, https://doi: 10.1007/s00395-022-00946-3.
  12. First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-11C-Me-NB1.
    Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M Godbersen, Leo R Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker, Simon M Ametamey
    J Nucl Med, June 2022, https://doi: 10.2967/jnumed.121.262427.
  13. Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery.
    Nicolai Huebner, Sazan Rasul, Pascal Baltzer, Paola Clauser, Karl Hermann Grubmüller, Markus Mitterhauser, Marcus Hacker, Axel Heidenreich, Pawel Rajwa, Harun Fajkovic, Shahrokh F Shariat, Bernhard Grubmüller
    Eur Urol Open Sci, May 2022, https://doi.org/10.1016/j.euros.2022.04.003.
  14. Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD−L1.
    Nedra Jouini, Jens Cardinale, Thomas L Mindt
    ChemMedChem, April 2022,  https://doi.org/10.1002/cmdc.202200091
  15. KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
    Tanja Limberger, Michaela Schlederer, Karolina Trachtová, Ines Garces de los Fayos Alonso, Jiaye Yang, Sandra Högler, Christina Sternberg, Vojtech Bystry, Jan Oppelt, Boris Tichý, Margit Schmeidl, Petra Kodajova, Anton Jäger, Heidi A. Neubauer, Monika Oberhuber, Belinda S. Schmalzbauer, Sarka Pospisilova, Helmut Dolznig, Wolfgang Wadsak, Zoran Culig, Suzanne D. Turner, Gerda Egger, Sabine Lagger, Lukas Kenner
    Molecular Cancer, March 2022, https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-022-01542-8
  16. Experimental Nuclear Medicine Meets Tumor Biology.
    Theresa Balber, Loan Tran, Katarína Benčurová, Julia Raitanen, Gerda Egger, Markus Mitterhauser
    Pharmaceuticals (Basel), Februar 2022, doi: 10.3390/ph15020227
  17. Simultaneous radiomethylation of [11C]harmine and [11C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual.
    Chrysoula Vraka, Matej Murgaš, Lucas Rischka, Barbara Katharina Geist, Rupert Lanzenberger, Gregor Gryglewski, Thomas Zenz, Wolfgang Wadsak, Markus Mitterhauser, Marcus Hacker, Cécile Philippe, Verena Pichler
    Scientific Reports, Februar 2022, https://doi.org/10.1038/s41598-022-06906-0
  18. Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies.
    Thomas Dillinger, Raheleh Sheibani-Tezerji, Walter Pulverer, Ines Stelzer, Melanie R. Hassler, Janine Scheibelreiter, Carlos Uziel Pérez Malla, Madeleine Kuroll, Sandra Domazet, Elisa Redl, Sarah Ely, Stefanie Brezina, Andreas Tiefenbacher, Katharina Rebhan, Nicolai Hübner, Bernhard Grubmüller, Markus Mitterhauser, Marcus Hacker, Andreas Weinhaeusel, Judit Simon, Markus Zeitlinger, Andrea Gsur, Gero Kramer, Shahrokh F. Shariat, Lukas Kenner, Gerda Egger
    Moleculas Cancer, January 2022, https://doi.org/10.1186/s12943-021-01445-0

2021

  1. Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Aepsis: A Review.
    Maria Sanz Codina, Markus Zeitlinger
    Clinical Pharmacokinetics [currently in print]
  2. Unexpected transformation of n.c.a. [ 111 In]InCl 3 in stock solutions into an unreactive [ 111 In]In-species.
    Carolina Giammei, Nedra Jouini, Marie R Brandt, Stefanie Frey, Thomas L Mindt, Jens Cardinale
    Appl Radiat Isot, December 2021, https://doi.org/10.1016/j.apradiso.2021.110037
  3. DNA hypomethylation leads to cGAS-induced autoinflammation in the epidermis.
    Mirjam A Beck, Heinz Fischer, Lisa M Grabner, Tamara Groffics, Mircea Winter, Simone Tangermann, Tina Meischel, Barbara Zaussinger-Haas, Patrick Wagner, Carina Fischer, Christina Folie, Julia Arand, Christian Schöfer, Bernard Ramsahoye, Sabine Lagger, Georg Machat, Gregor Eisenwort, Stephanie Schneider, Alexandra Podhornik, Michael Kothmayer, Ursula Reichart, Martin Glösmann, Ido Tamir, Michael Mildner, Raheleh Sheibani-Tezerji, Lukas Kenner, Peter Petzelbauer, Gerda Egger, Maria Sibilia, Andrea Ablasser, Christian Seiser
    EMBO J, November 2021, https://doi.org/ 10.15252/embj.2021108234
  4. Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer.
    Robert Wiebringhaus, Matteo Pecoraro, Heidi A Neubauer, Karolína Trachtová, Bettina Trimmel, Maritta Wieselberg, Jan Pencik, Gerda Egger, Christoph Krall, Richard Moriggl, Matthias Mann, Brigitte Hantusch, Lukas Kenner
    Cancers (Basel, November 2021, https://doi.org/10.3390/cancers13236036
  5. First-in-human brain PET imaging of the GluN2B-containing N-methyl-D-aspartate receptor with ( R)- 11C-Me-NB1.
    Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgas, Godber Godbersen, Leo Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt , Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker, Simon M Ametamey
    J Nucl Med, October 2021, https://doi.org/10.2967/jnumed.121.262427
  6. Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value.
    Walter Pulverer, Kristi Kruusmaa, Silvia Schönthaler, Jasmin Huber, Marko Bitenc, Thomas Bachleitner-Hofmann, Jagdeep Singh Bhangu, Rudolf Oehler, Gerda Egger, Andreas Weinhäusel
    Curr Issues Mol Biol, October 2021, https://doi.org/10.3390/cimb43030100
  7. The Race for Hydroxamate-Based Zirconium-89 Chelators.
    Irene V J Feiner, Marie Brandt, Joseph Cowell, Tori Demuth, Danielle Vugts, Gilles Gasser, Thomas L Mindt
    Cancers (Basel), September 2021, https://doi.org/10.3390/cancers13174466
  8. If It Works, Don’t Touch It? A Cell-Based Approach to Studying 2-[ 18 F]FDG Metabolism
    Eva-Maria Klebermass, Mahshid Mahmudi, Barbara K Geist, Verena Pichler, Chrysoula Vraka, Theresa Balber, Anne Miller, Arvand Haschemi, Helmut Viernstein, Nataliya Rohr-Udilova, Marcus Hacker, Markus Mitterhauser
    Pharmaceuticals (Basel), September 2021, https://doi.org/10.3390/ph14090910
  9. Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
    Tim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, Michael Weber, Bernhard Grubmüller, Gero Kramer, Shahrokh F Shariat, Markus Mitterhauser, Stefan Schmitl, Chrysoula Vraka, Alexander R Haug, Marcus Hacker, Markus Hartenbach, Sazan Rasul
    Curr Oncol, Septemeber 2021, https://doi.org/10.3390/curroncol28050315
  10. Cross-Modality Imaging of Murine Tumor Vasculature-a Feasibility Study.
    Lydia M Zopf, Patrick Heimel, Stefan H Geyer, Anoop Kavirayani, Susanne Reier, Vanessa Fröhlich, Alexander Stiglbauer-Tscholakoff, Zhe Chen, Lukas Nics, Jelena Zinnanti, Wolfgang Drexler, Markus Mitterhauser, Thomas Helbich, Wolfgang J Weninger, Paul Slezak, Anna Obenauf, Katja Bühler, Andreas Walter
    Mol Imaging Biol, June 2021, https://doi.org/10.1007/s11307-021-01615-y
  11. Development and in vitro evaluation of new bifunctional 89 Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications.
    Benedikt Klasen, Daniel Lemcke, Thomas L Mindt, Gilles Gasser, Frank Rosch
    Nucl Med Biol, June 2021, https://doi.org/10.1016/j.nucmedbio.2021.06.007
  12. Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [ 68 Ga]Ga-PSMA-11 PET/MRI.
    J L Papp, C P Spielvogel, B Grubmüller, M Grahovac, D Krajnc, B Ecsedi, R A M Sareshgi, D Mohamad, M Hamboeck, I Rausch, M Mitterhauser, W Wadsak, A R Haug, L Kenner, P Mazal, M Susani, S Hartenbach, P Baltzer, T H Helbich, G Kramer, S F Shariat, T Beyer, M Hartenbach, M Hacker
    Eur J Nucl Med Mol Imaging, June 2021, https://doi.org/10.1007/s00259-020-05140-y
  13. PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in 11 C-Methionine PET and Survival
    Tatjana Traub-Weidinger, Nina Poetsch, Adelheid Woehrer, Eva-Maria Klebermass, Tatjana Bachnik, Matthias Preusser, Mario Mischkulnig, Barbara Kiesel, Georg Widhalm, Markus Mitterhauser, Marcus Hacker, Oskar Koperek
    J Pers Med, June 2021, https://doi.org/10.3390/jpm11070624
  14. Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin 177 Lu-PP-F11N.
    Nathalie M Grob, Roger Schibli, Martin Béhé, Thomas L Mindt
    Cancers (Basel), May 2021, https://doi.org/10.3390/cancers13112629
  15. Response and Toxicity to the Second Course of 3 Cycles of 177 Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer.
    Sazan Rasul, Tim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, Bernhard Grubmüller, Gero Kramer, Shahrokh F Shariat, Harald Eidherr, Markus Mitterhauser, Chrysoula Vraka, Werner Langsteger, Marcus Hacker, Alexander R Haug
    Cancers (Basel), May 2021,  https://doi.org/10.3390/cancers13102489
  16. 1,5-Disubstituted 1,2,3-Triazoles as Amide Bond Isosteres Yield Novel Tumor-Targeting Minigastrin Analogs.
    Nathalie M Grob, Roger Schibli, Martin Béhé, Ibai E Valverde, Thomas L Mindt
    ACS Med Chem Lett, March 2021, https://doi.org/10.1021/acsmedchemlett.0c00636
  17. A Microdosing Study with 99m Tc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.
    Oana C Kulterer, Sarah Pfaff, Wolfgang Wadsak, Nathalie Garstka, Mesut Remzi, Chrysoula Vraka, Lukas Nics, Markus Mitterhauser, Franziska Bootz, Samuele Cazzamalli, Nikolaus Krall, Dario Neri, Alexander R Haug
    J Nucl Med, March 2021, https://doi.org/10.2967/jnumed.120.245530
  18. Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
    Nic Gillings, Olaug Hjelstuen, Jim Ballinger, Martin Behe, Clemens Decristoforo, Philip Elsinga, Valentina Ferrari, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L Mindt, Oliver Neels, Meltem Ocak, Marianne Patt, Sergio Todde
    EJNMMI Radiopharm Chem, February 2021, https://doi.org/10.1186/s41181-021-00123-2
  19. Discovery of melanin-concentrating hormone receptor 1 in brown adipose tissue.
    Cécile Philippe, Eva-Maria Klebermass, Theresa Balber, Oana C Kulterer, Markus Zeilinger, Gerda Egger, Monika Dumanic, Carsten T Herz, Florian W Kiefer, Christian Scheuba, Thomas Scherer, Clemens Fürnsinn, Chrysoula Vraka, Katharina Pallitsch, Helmut Spreitzer, Wolfgang Wadsak, Helmut Viernstein, Marcus Hacker, Markus Mitterhauser
    Annals of the New York Academy of Sciences, January 2021, https://doi.org/10.1111/nyas.14563
  20. Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2.
    Claudia A Hana, Eva-Maria Klebermass, Theresa Balber, Markus Mitterhauser, Ruth Quint, Yvonne Hirtl, Antonia Klimpke, Sophie Somloi, Juliana Hutz, Elisabeth Sperr, Paulina Eder, Jana Jašprová, Petra Valášková, Libor Vítek, Elke Heiss, Karl-Heinz Wagner
    Front Pharmacol, January 2021, https://doi.org/10.3389/fphar.2020.636533

2020

  1. Association of dopamine D 2/3 receptor binding potential measured using PET and [ 11 C]-(+)-PHNO with post-mortem DRD 2/3 gene expression in the human brain.
    Arkadiusz Komorowski, Ana Weidenauer, Matej Murgaš, Ulrich Sauerzopf, Wolfgang Wadsak, Markus Mitterhauser, Martin Bauer, Marcus Hacker, Nicole Praschak-Rieder, Siegfried Kasper, Rupert Lanzenberger, Matthäus Willeit
    Neuroimage, December 2020, https://doi.org/10.1016/j.neuroimage.2020.117270
  2. ALK-transformed mature T lymphocytes restore early thymus progenitor features.
    Annabelle Congras, Coralie Hoareau-Aveilla, Nina Caillet, Marie Tosolini, Patrick Villarese, Agata Cieslak, Laura Rodriguez, Vahid Asnafi, Elisabeth Macintyre, Gerda Egger, Pierre Brousset, Laurence Lamant, Fabienne Meggetto
    J Clin Invest, December 2020, https://doi.org/10.1172/JCI134990
  3. Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.
    Elisa Redl, Raheleh Sheibani-Tezerji, Crhistian de Jesus Cardona, Patricia Hamminger, Gerald Timelthaler, Melanie Rosalia Hassler, Maša Zrimšek, Sabine Lagger, Thomas Dillinger, Lorena Hofbauer, Kristina Draganić, Andreas Tiefenbacher, Michael Kothmayer, Charles H Dietz, Bernard H Ramsahoye, Lukas Kenner, Christoph Bock, Christian Seiser, Wilfried Ellmeier, Gabriele Schweikert, Gerda Egger
    Life Sci Alliance, December 2020, https://doi.org/10.26508/lsa.202000794
  4. A Network-Based Mixed Methods Approach to Analyze Current Perspectives on Personalized Oncological Medicine in Austria.
    Ines Viktoria Stelzer, Anna Sierawska, Alena Buyx and Judit Simon
    Pers. Med., December 2020, https://doi.org/10.3390/jpm10040276
  5. Assessment of left and right ventricular functional parameters using dynamic dual-tracer [ 13 N]NH3 and [ 18 F]FDG PET/MRI.
    Sazan Rasul, Dietrich Beitzke, Tim Wollenweber, Ivo Rausch, Martin Lyngby Lassen, Marie Elisabeth Stelzmüller, Markus Mitterhauser, Verena Pichler, Thomas Beyer, Christian Loewe, Marcus Hacker
    J Nucl Cardiol, October 2020, https://doi.org/10.1007/s12350-020-02391-y
  6. Enhanced arecoline derivatives as muscarinic acetylcholine receptor M1 ligands for potential application as PET radiotracers.
    Marius Ozenil, Katharina Pacher, Theresa Balber, Chrysoula Vraka, Alexander Roller, Wolfgang Holzer, Helmut Spreitzer, Markus Mitterhauser, Wolfgang Wadsak, Marcus Hacker, Verena Pichler
    Eur J Med Chem, October 2020, https://doi.org/10.1016/j.ejmech.2020.112623
  7. Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
    Osman Aksoy , Jan Pencik, Markus Hartenbach, Ali A Moazzami, Michaela Schlederer, Theresa Balber, Adam Varady, Cecile Philippe, Pascal A Baltzer, Bismoy Mazumder, Jonathan B Whitchurch, Christopher J Roberts, Andrea Haitel, Merima Herac, Martin Susani, Markus Mitterhauser, Rodrig Marculescu, Judith Stangl-Kremser, Melanie R Hassler, Gero Kramer, Shahrokh F Shariat, Suzanne D Turner, Boris Tichy, Jan Oppelt  17 , Sarka Pospisilova, Sabrina Hartenbach, Simone Tangermann, Gerda Egger, Heidi A Neubauer, Richard Moriggl, Zoran Culig, Georg Greiner, Gregor Hoermann, Marcus Hacker, David M Heery, Olaf Merkel, Lukas Kenner
    Int J Cancer, October 2020, https://doi.org/10.1002/ijc.33332
  8. Prediction of response and survival after standardized treatment with 7400 MBq 177 Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer.
    Sazan Rasul, Markus Hartenbach, Tim Wollenweber, Elisabeth Kretschmer-Chott, Bernhard Grubmüller, Gero Kramer, Shahrokh Shariat, Wolfgang Wadsak, Markus Mitterhauser, Verena Pichler, Chrysoula Vraka, Marcus Hacker, Alexander R Haug
    Eur J Nucl Med Mol Imaging, October 2020, https://doi.org/10.1007/s00259-020-05082-5
  9. Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
    Ilaria Guccini, Ajinkya Revandkar, Mariantonietta D’Ambrosio, Manuel Colucci, Emiliano Pasquini, Simone Mosole, Martina Troiani, Daniela Brina, Raheleh Sheibani-Tezerji, Angela Rita Elia, Andrea Rinaldi, Nicolò Pernigoni, Jan Hendrik Rüschoff, Susanne Dettwiler, Angelo M De Marzo, Emmanuel S Antonarakis, Costanza Borrelli, Andreas E Moor, Ramon Garcia-Escudero, Abdullah Alajati, Giuseppe Attanasio, Marco Losa, Holger Moch, Peter Wild, Gerda Egger, Andrea Alimonti
    Cancer Cell, October 2020, https://doi.org/10.1016/j.ccell.2020.10.012
  10. Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89 Zr-immuno-PET.
    Marion Chomet, Maxime Schreurs, Maria J Bolijn, Mariska Verlaan, Wissam Beaino, Kari Brown, Alex J Poot, Albert D Windhorst, Herman Gill, Jan Marik, Simon Williams, Joseph Cowell, Gilles Gasser, Thomas L Mindt, Guus A M S van Dongen, Danielle J Vugts
    Eur J Nucl Med Mol Imaging, September 2020, https://doi.org/10.1007/s00259-020-05002-7
  11. Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [ 68 Ga]Ga-PSMA ligand PET/CT(MRI).
    Bernhard Grubmüller, Victoria Jahrreiss, Nicolai Huebner, Markus Mitterhauser, Judith Stangl-Kremser, Karl Hermann Grubmüller, Pascal Baltzer, Marcus Hacker, Gregor Goldner, Shahrokh F Sharia, Sazan Rasul
    Prostate Cancer Prostatic Dis, September 2020, https://doi.org/10.1038/s41391-020-00294-0
  12. Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.
    Dafina Ilijazi, Walter Pulverer, Iris E Ertl, Ursula Lemberger, Shoji Kimura, Mohammad Abufaraj, David D’Andrea, Benjamin Pradere, Andreas Bruchbacher, Anna Graf, Francesco Soria, Martin Susani, Andrea Haitel, Luca Molinaro, Armin Pycha, Evi Comploj, Stephan Pabinger, Andreas Weinhäusel, Gerda Egger, Shahrokh F Shariat, Melanie R Hassler
    Cells, August 2020, https://doi.org/10.3390/cells9081839
  13. Single Peptide Backbone Surrogate Mutations to Regulate Angiotensin GPCR Subtype Selectivity.
    Eirinaios I Vrettos, Ibai E Valverde, Alba Mascarin, Patrick N Pallier, Linda Cerofolini, Marco Fragai, Giacomo Parigi, Baydaa Hirmiz, Nick Bekas, Nathalie M Grob, Evgenios Κ Stylos, Hamidreza Shaye, Mark Del Borgo, Marie-Isabel Aguilar, Francesca Magnani, Nelofer Syed, Timothy Crook, Emal Waqif, Essam Ghazaly, Vadim Cherezov, Robert E Widdop, Claudio Luchinat, Adina T Michael-Titus, Thomas L Mindt, Andreas G Tzakos
    Chemistry – A European Journal, August 2020, https://doi.org/10.1002/chem.202000924
  14. 1,4-Disubstituted 1,2,3-Triazoles as Amide Bond Surrogates for the Stabilisation of Linear Peptides with Biological Activity.
    Lisa-Maria Rečnik, Wolfgang Kandioller, Thomas L Mindt
    Molecules, August 2020, https://doi.org/10.3390/molecules25163576
  15. The relationship between cholecystokinin secretion and pancreatic [11C]methionine uptake in patients after partial pancreaticoduodenectomy.
    Emanuel Steiner, Lukas Kazianka, Robert Breuer, Marcus Hacker, Wolfgang Wadsak, Markus Mitterhauser, Jens F. Rehfeld, Georgios Karanikas and Johannes Miholic.
    Annals of Nuclear Medicine, July 2020, https://doi.org/10.1007/s12149-020-01492-5
  16. “Magnitude of Clinical Benefit” of solid tumour drugs and their real-world application in the Austrian health care setting.
    Nicole Grössmann, Martin Robausch, Wolfgang Willenbacher, Sarah Wolf, Judit Simon, Claudia Wild.
    Journal of Cancer Policy, July 2020, https://doi.org/10.1016/j.jcpo.2020.100235
  17. Radiolabelling of the octadentate chelators DFO* and oxoDFO* with zirconium-89 and gallium-68.
    Marie Brandt, Joseph Cowell, Margaret L. Aulsebrook, Gilles Gasser and Thomas L. Mindt.
    Journal of Biological Inorganic Chemistry, July 2020, https://doi.org/10.1007/s00775-020-01800-4
  18. From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses.
    Julijan Kabiljo, Johannes Laengle, Michael Bergmann
    Cell Death Discov, June 2020, https://doi.org/10.1038/s41420-020-0284-1
  19. Sorbitol as a Polar Pharmacological Modifier to Enhance the Hydrophilicity of 99mTc-Tricarbonyl-Based Radiopharmaceuticals.
    Carolina Giammei, Theresa Balber, Katarina Benčurová, Jens Cardinale, Neydher Berroterán-Infante, Marie Brandt, Nedra Jouini, Marcus Hacker, Markus Mitterhauser and Thomas L. Mindt.
    Molecules, June 2020, https://doi.org/10.3390/molecules25112680
  20. Vorinostat in the acute neuroinflammatory form of X‐linked adrenoleukodystrophy.
    Bettina Zierfuss, Isabelle Weinhofer, Jörn‐Sven Kühl, Wolfgang Köhler, Annette Bley, Katharina Zauner, Johannes Binder, Ksenija Martinović, Christian Seiser, Christoph Hertzberg, Stephan Kemp, Gerda Egger, Gerda Leitner, Jan Bauer, Christoph Wiesinger, Markus Kunze, Sonja Forss‐Petter, Johannes Berger.
    Annals of Clinical and Translational Neurology, May 2020, https://doi.org/10.1002/acn3.51015
  21. Attenuation of canonical NF-κB signaling maintains function and stability of human Treg.
    Liesa S. Ziegler, Marlene C. Gerner, Ralf L. J. Schmidt, Doris Trapin, Peter Steinberger, Winfried F. Pickl, Christian Sillaber, Gerda Egger, Ilse Schwarzinger, Klaus G. Schmetterer.
    The FEBS Journal, May 2020, https://doi.org/10.1111/febs.15361
  22. Triazolo-Peptidomimetics: Novel Radiolabeled Minigastrin Analogs for Improved Tumor Targeting.
    Nathalie M. Grob, Daniel Häussinger, Xavier Deupi, Roger Schibli, Martin Behe, and Thomas L. Mindt.
    Journal of Medicinal Chemistry, May 2020, https://doi.org/10.1021/acs.jmedchem.9b01936
  23. Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions.
    Nathalie M. Grob, Sarah Schmid, Roger Schibli, Martin Behe, and Thomas L. Mindt.
    Journal of Medicinal Chemistry, May 2020, https://doi.org/10.1021/acs.jmedchem.9b01937
  24. Machine learning classification of ADHD and HC by multimodal serotonergic data.
    A Kautzky, T Vanicek, C Philippe, G S Kranz, W Wadsak, M Mitterhauser, A Hartmann, A Hahn, M Hacker, D Rujescu, S Kasper, R Lanzenberger.
    Translational Psychiatry, April 2020, https://doi.org/10.1038/s41398-020-0781-2
  25. Publicly accessible evidence of health-related quality of life benefits associated with cancer drugs approved by the European Medicines Agency between 2009 and 2015.
    Nicole Grössmann, Martin Robausch, Eleen Rothschedl, Claudia Wild, Judit Simon.
    European Journal of Cancer, April 2020, https://doi.org/10.1016/j.ejca.2020.01.020
  26. STAT 3‐dependent analysis reveals PDK 4 as independent predictor of recurrence in prostate cancer.
    Monika Oberhuber, Matteo Pecoraro, Mate Rusz, Georg Oberhuber, Maritta Wieselberg, Peter Haslinger, Elisabeth Gurnhofer, Michaela Schlederer, Tanja Limberger, Sabine Lagger, Jan Pencik, Petra Kodajova, Sandra Högler, Georg Stockmaier, Sandra Grund‐Gröschke, Fritz Aberger, Marco Bolis, Jean‐Philippe Theurillat, Robert Wiebringhaus, Theresa Weiss, Andrea Haitel, Marc Brehme, Wolfgang Wadsak, Johannes Griss, Thomas Mohr, Alexandra Hofer, Anton Jäger, Jürgen Pollheimer, Gerda Egger, Gunda Koellensperger, Matthias Mann, Brigitte Hantusch, Lukas Kenner.
    Molecular Systems Biology, April 2020, https://doi.org/10.15252/msb.20199247
  27. Synthesis, Modification, and Biological Evaluation of a Library of Novel Water-Soluble Thiopyridone-Based Organometallic Complexes and Their Unexpected (Biological) Behavior.
    Sophia Harringer, Barbara Happl, Marius Ozenil, Caroline Kast, Michaela Hejl, Debora Wernitznig, Anton A Legin, Andreas Schweikert, Natalie Gajic, Alexander Rolle, Gunda Koellensperger, Michael A Jakupec, Wolfgang Kandioller, Bernhard K Keppler.
    Chemistry – A European Journal, April 2020,  https://doi.org/10.1002/chem.201905546
  28. Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI.
    Sazan Rasul, Barbara Katharina Geist, Helmut Brath, Pascal Baltzer, Lalith Kumar Shiyam Sundar, Verena Pichler, Markus Mitterhauser, Alexandra Kautzky-Willer, Marcus Hacker
    BMJ Open Diabetes Research & Care, March 2020, https://doi.org/10.1136/bmjdrc-2019-001135
  29. EANM guideline on the validation of analytical methods for radiopharmaceuticals.
    Nic Gillings, Sergio Todde, Martin Behe, Clemens Decristoforo, Philip Elsinga, Valentina Ferrari, Olaug Hjelstuen, Petra Kolenc Peitl, Jacek Koziorowski, Peter Laverman, Thomas L. Mindt, Meltem Ocak, and Marianne Patt
    EJNMMI Radiopharmacy and Chemistry, February 2020, https://doi.org/10.1186/s41181-019-0086-z
  30. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D2/3 receptor agonist radioligand study
    Ana Weidenauer, Martin Bauer, Ulrich Sauerzopf, Lucie Bartova, Lukas Nics, Sarah Pfaff, Cecile Philippe, Neydher Berroterán-Infante, Verena Pichler, Bernhard M. Meyer, Ulrich Rabl, Patrick Sezen, Paul Cumming, Thomas Stimpfl, Harald H. Sitte, Rupert Lanzenberger, Nilufar Mossaheb, Alexander Zimprich, Pablo Rusjan, Georg Dorffner, Markus Mitterhauser, Marcus Hacker, Lukas Pezawas, Siegfried Kasper, Wolfgang Wadsak, Nicole Praschak-Rieder, Matthäus Willeit
    Translational Psychiatry, January 2020, https://doi.org/10.1038/s41398-019-0681-5
  31. Utility of Absolute Quantification in Non-lesional Extratemporal Lobe Epilepsy Using FDG PET/MR Imaging.
    Tatjana Traub-Weidinger, Otto Muzik, Lalith Kumar Shiyam Sundar, Susanne Aull-Watschinger, Thomas Beyer, Marcus Hacker, Andreas Hahn, Gregor Kasprian, Eva-Maria Klebermass, Rupert Lanzenberger, Markus Mitterhauser, Magdalena Pilz, Ivo Rausch, Lucas Rischka, Wolfgang Wadsak and Ekaterina Pataraia
    Frontiers in Neurology, January 2020, https://doi.org/10.3389/fneur.2020.00054
  32. Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis.
    Johannes Laengle, Julijan Kabiljo, Leah Hunter, Jakob Homola, Sophie Prodinger, Gerda Egger and Michael Bergmann
    Journal for ImmunoTherapy of Cancer, January 2020, https://doi.org/10.1136/jitc-2019-000195
  33. Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT1A Receptor by Combining In Vivo PET and Allen Human Brain Atlas Data.
    Jakob Unterholzner, Gregor Gryglewski, Cecile Philippe, Rene Seiger, Verena Pichler, Godber M Godbersen, Neydher Berroterán-Infante, Matej Murgaš, Andreas Hahn, Wolfgang Wadsak, Markus Mitterhauser, Siegfried Kasper, Rupert Lanzenberger
    Cerebral Cortex, January 2020, https://doi.org/10.1093/cercor/bhz341

2019

  1. Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI.
    Lucas Rischka, Gregor Gryglewski, Neydher Berroterán-Infante, Ivo Rausch, Gregory Miles James, Manfred Klöbl, Helen Sigurdardottir, Markus Hartenbach, Andreas Hahn, Wolfgang Wadsak, Markus Mitterhauser, Thomas Beyer, Siegfried Kasper, Daniela Prayer, Marcus Hacker, and Rupert Lanzenberger
    Frontiers in Physiology, November 2019 Nov, https://doi.org/10.3389/fphys.2019.01422
  2. Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks.
    Sazan Rasul, Marcus Hacker, Elisabeth Kretschmer-Chott, Asha Leisser, Bernhard Grubmüller, Gero Kramer, Shahrokh Shariat, Wolfgang Wadsak, Markus Mitterhauser, Markus Hartenbach and Alexander R. Haug
    European Journal of Nuclear Medicine and Molecular Imaging, November 2019, https://doi.org/10.1007/s00259-019-04584-1
  3. Toward the Optimization of (+)-[11C]PHNO Synthesis: Time Reduction and Process Validation.
    Sarah Pfaff, Cécile Philippe, Lukas Nics, Neydher Berroterán-Infante, Katharina Pallitsch, Christina Rami-Mark, Ana Weidenauer, Ulrich Sauerzopf, Matthäus Willeit, Markus Mitterhauser, Marcus Hacker, Wolfgang Wadsak, and Verena Pichler
    Contrast Media and Molecular Imaging, September 2019, https://doi.org/10.1155/2019/4292596
  4. Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4
    Simon A. M. Kaeppeli, Roger Schibli, Thomas L. Mindt & Martin Behe
    EJNMMI Radiopharmacy and Chemistry, May 2019,  https://doi.org/10.1186/s41181-019-0060-9
  5. Brain glucose uptake during transcranial direct current stimulation measured with functional [18F]FDG-PET.
    Christoph Kraus, Andreas Hahn, Helen Sigurdardottir, Benjamin Spurny, Wolfgang Wadsak, Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger
    Brain Imaging and Behavior, October 2019, https://doi.org/10.1007/s11682-019-00195-4
  6. Response assessment using [68Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer.
    Bernhard Grubmüller, Sazan Rasul, Pascal Baltzer, Harun Fajkovic, David D’Andrea, Florian Berndl, Agnes Maj‐Hes, Karl Hermann Grubmüller, Markus Mitterhauser, Wolfgang Wadsak, Sarah Pfaff, Shahrokh F. Shariat, Marcus Hacker, Gero Kramer, Markus Hartenbach
    The Prostate, October 2019, https://doi.org/10.1002/pros.23919
  7. Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy.
    Mohammad Abufaraj, Bernhard Grubmüller, Markus Zeitlinger, Gero Kramer, Christian Seitz, Andrea Haitel, Pascal Baltzer, Marcus Hacker, Wolfgang Wadsak, Sarah Pfaff, Tomasz Wiatr, Markus Mitterhauser, Shahrokh F. Shariat, and Markus Hartenbach
    European Journal of Nuclear Medicine and Molecular Imaging, September 2019, https://doi.org/10.1007/s00259-019-04361-0
  8. Bioconjugation Methods for Radiopharmaceutical Chemistry
    Jens Cardinale, Carolina Giammei, Nedra Jouini, and Thomas L. Mindt
    in Radiopharmaceutical Chemistry by J. Lewis, A. D. Windhorst, B. Zeglis (ed.), pages 449-466, Springer 2019
  9. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET.
    Helen L. Sigurdardottir, Georg S. Kranz, Christina Rami-Mark, Gregory M. James, Thomas Vanicek, Gregor Gryglewski, Neydher Berroterán-Infante, Alexander Kautzky, Marius Hienert, Tatjana Traub-Weidinger, Markus Mitterhauser, Wolfgang Wadsak, Anette M. Hartmann, Marcus Hacker, Dan Rujescu, Siegfried Kasper and Rupert Lanzenberger
    Molecular Psychiatry, August 2019, https://doi.org/10.1038/s41380-019-0461-x
  10. The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis.
    Stephen P. Ducray, Karthikraj Natarajan, Gavin D. Garland, Suzanne D. Turner, and Gerda Egger
    Cancers, July 2019, https://doi.org/10.3390/cancers11081074
  11. Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR.
    Leo R. Silberbauer, Gregor Gryglewski, Neydher Berroterán-Infante, Lucas Rischka, Thomas Vanicek, Verena Pichler, Marius Hienert, Alexander Kautzky, Cecile Philippe, Godber M. Godbersen, Chrysoula Vraka, Gregory M. James, Wolfgang Wadsak, Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Andreas Hahn and Rupert Lanzenberger
    Frontiers in Molecular Neuroscience, July 2019, https://doi.org/10.3389/fnmol.2019.00172
  12. In vitro Radiopharmaceutical Evidence for MCHR1 Binding Sites in Murine Brown Adipocytes.
    Theresa Balber, Katarína Benčurová, Florian Wolfgang Kiefer, Oana Cristina Kulterer, Eva-Maria Klebermass, Gerda Egger, Loan Tran, Karl-Heinz Wagner, Helmut Viernstein, Katharina Pallitsch, Helmut Spreitzer, Marcus Hacker, Wolfgang Wadsak, Markus Mitterhauser, and Cécile Philippe
    Frontiers in Endocrinology, June 2019, https://doi.org/10.3389/fendo.2019.00324
  13. Cost-of-illness studies in nine Central and Eastern European countries.
    Valentin Brodszky, Zsuzsanna Beretzky, Petra Baji, Fanni Rencz, Márta Péntek, Alexandru Rotar, Konstantin Tachkov, Susanne Mayer, Judit Simon, Maciej Niewada, Rok Hren, László Gulácsi
    The European Journal of Health Economics, June 2019, https://doi.org/10.1007/s10198-019-01066-x
  14. Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [68Ga]Ga-Pentixafor-PET/MRI.
    Alexander R., Asha Leisser, Wolfgang Wadsak, Markus Mitterhauser, Sarah Pfaff, Saskia Kropf, Hans-Juergen Wester, Marcus Hacker, Markus Hartenbach, Barbara Kiesewetter-Wiederkehr, Markus Raderer, Marius E. Mayerhoefer
    Theranostics, May 2019, https://doi.org/10.7150/thno.31032
  15. The societal costs of chronic pain and its determinants: The case of Austria.
    Susanne Mayer, Jonah Spickschen, Viktoria Stein, Richard Crevenna, Thomas E. Dorner, and Judit Simon
    PLoS One, March 2019, https://doi.org/10.1371%2Fjournal.pone.0213889
  16. Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015.
    Nicole Grössmann, Martin Robausch, Katharina Rosian, Claudia Wild, and Judit Simon
    European Journal of Cancer, March 2019, https://doi.org/10.1016/j.ejca.2018.12.026
  17. (R)-[18F]NEBIFQUINIDE: A promising new PET tracer for TSPO imaging.
    Neydher Berroterán-Infante, Thomas Kalina, Lukas Fetty, Victoria Janisch, Ramona Velasco, Chrysoula Vraka, Marcus Hacker, Alexander R. Haug, Katharina Pallitsch, Wolfgang Wadsak, and Markus Mitterhauser
    European Journal of Medicinal Chemistry, August 2019, https://doi.org/10.1016/j.ejmech.2019.05.008
  18. Manganese in PET imaging – opportunities and challenges.
    Marie Brandt, Jens Cardinale, Ivo Rausch, and Thomas L. Mindt
    Journal of Labelled Compounds and Radiopharmaceuticals, May 2019, https://doi.org/10.1002/jlcr.3754
  19. Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria.
    Megan S. Lim, Thomas Beyer, Anna Babayan, Michael Bergmann, Marc Brehme, Alena Buyx, Johannes Czernin, Gerda Egger, Kojo S. J. Elenitoba-Johnson, Brigitte Gückel, Angela Jačan, Helmuth Haslacher, Rodney J. Hicks, Lukas Kenner, Martin Langanke, Markus Mitterhauser, Bernd J. Pichler, Helmut R. Salih, Roger Schibli, Stefan Schulz, John Simecek, Judit Simon, Marcelo de Oliveira Soares, Ulrich Stelzl, Wolfgang Wadsak, Kurt Zatloukal, Markus Zeitlinger, and Marcus Hacker
    Molecular Imaging and Biology, May 2019, https://doi.org/10.1007/s11307-019-01361-2
  20. Status of the ‘consensus nomenclature rules in radiopharmaceutical sciences’ initiative
    Heinz H. Coenen, Antony D. Gee, Michael Adam, Gunnar Antoni, Cathy S. Cutler, Yasuhisa Fujibayashi, Jae Min Jeong, Robert H. Mach, Thomas L. Mindt, Victor W. Pike, and Albert D. Windhorst
    Nuclear Medicine and Biology, May 2019, https://doi.org/10.1016/j.nucmedbio.2019.05.001
  21. Modeling the acute pharmacological response to selective serotonin reuptake inhibitors in human brain using simultaneous PET/MR imaging.
    Gryglewski Gregor, Klöbl Manfred, Berroterán-Infante Neydher, Rischka Lucas, Balber Theresa, Vanicek Thomas, Pichler Verena, Kautzky Alexander, Klebermass Eva-Maria, Reed Murray Bruce, Vraka Chrysoula, Hienert Marius, James Gregory Miles, Silberbauer Leo, Godbersen Godber Mathis, Unterholzner Jakob, Michenthaler Paul, Hartenbach Markus, Winkler-Pjrek Edda, Wadsak Wolfgang, Mitterhauser Markus, Hahn Andreas, Hacker Marcus, Kasper Siegfried, Lanzenberger Rupert
    European Neuropsychopharmacology, May 2019, https://doi.org/10.1016/j.euroneuro.2019.04.001
  22. Multimodal [18F]FDG PET/CT is a direct readout for inflammatory bone repair: a longitudinal study in TNFα transgenic mice.
    Silvia Hayer, Markus Zeilinger, Volker Weiss, Monika Dumanic, Markus Seibt, Birgit Niederreiter, Tetyana Shvets, Florian Pichler, Wolfgang Wadsak, Bruno K. Podesser, Thomas H. Helbich, Marcus Hacker, Josef S. Smolen, Kurt Redlich, and Markus Mitterhauser
    Journal of Bone and Mineral Research, May 2019, https://doi.org/10.1002/jbmr.3748
  23. Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.
    Bernhard Grubmüller, Daniela Senn, Gero Kramer, Pascal Baltzer, David D’Andrea, Karl Hermann Grubmüller, Markus Mitterhauser, Harald Eidherr, Alexander R. Haug, Wolfgang Wadsak, Sarah Pfaff, Shahrokh F. Shariat, Marcus Hacker, and Markus Hartenbach
    European Journal of Nuclear Medicine and Molecular Imaging, May 2019, https://doi.org/10.1007/s00259-018-4236-4
  24. The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography.
    Pia Baldinger-Melich, Gregor Gryglewski, Cécile Philippe, Gregory M. James, Chrysoula Vraka, Leo Silberbauer, Theresa Balber, Thomas Vanicek, Verena Pichler, Jakob Unterholzner, Georg S. Kranz, Andreas Hahn, Dietmar Winkler, Markus Mitterhauser, Wolfgang Wadsak, Marcus Hacker, Siegfried Kasper, Richard Frey, Rupert Lanzenberger
    Brain Stimulation, May 2019, https://doi.org/10.1016/j.brs.2018.12.976
  25. Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941.
    Chrysoula Vraka, Verena Pichler, Sarah Pfaff, Theresa Balber, Marcus Hacker, Markus Mitterhauser, Wolfgang Wadsak, Cecile Philippe
    Journal of visualized experiments: JoVE, April 2019, https://doi.org/10.3791/59557
  26. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT.
    Thomas Selim Nakuz, Filipe Portela Millinger, Karem El-Rabadi, Michael Weber, Verena Pichler, Wolfgang Wadsak, Markus Mitterhauser, Alexander Haug, Marcus Hacker, Georgios Karanikas, Peter Pietschmann, and Hermine Agis
    Anticancer Research, April 2019, https://doi.org/10.21873/anticanres.13304
  27. Optimization of the Automated Synthesis of [11C]mHED-Administered and Apparent Molar Activities.
    Chrysoula Vraka, Verena Pichler, Neydher Berroterán-Infante, Tim Wollenweber, Anna Pillinger, Maximilian Hohensinner, Lukas Fetty, Dietrich Beitzke, Xiang Li, Cecile Philippe, Katharina Pallitsch, Markus Mitterhauser, Marcus Hacker, and Wolfgang Wadsak
    Pharmaceuticals (Basel), March 2019, https://doi.org/10.3390%2Fph12010012
  28. Synthesis and in vitro evaluation of new translocator protein ligands designed for positron emission tomography.
    Alexander Thomas Kalina, Neydher Berroterán-Infante, Stefan Schmitl, Chrysoula Vraka, Marcus Hacker, Markus Mitterhauser, Katharina Pallitsch, and Wolfgang Wadsak
    Future Medicinal Chemistry, March 2019, https://doi.org/10.4155/fmc-2018-0444
  29. Mini-Review: Targeted radiopharmaceuticals incorporating reversible, low molecular weight albumin binders
    Marie Brandt, Jens Cardinale, Carolina Giammei, Xabier Guarrochena, Barbara Happl, Nedra Jouini, Thomas L. Mindt
    Nuclear Medicine and Biology, March 2019, https://doi.org/10.1016/j.nucmedbio.2019.01.006
  30. Binding Affinity of Some Endogenous and Synthetic TSPO Ligands Regarding the rs6971 Polymorphism.
    Neydher Berroterán-Infante, Monika Tadić, Marcus Hacker, Wolfgang Wadsak, and Markus Mitterhauser
    International Journal of Molecular Sciences, February 2019, https://doi.org/10.3390/ijms20030563
  31. Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression.
    Alexander Kautzky, Gregory M. James, Cecile Philippe, Pia Baldinger-Melich, Christoph Kraus, Georg S. Kranz, Thomas Vanicek, Gregor Gryglewski, Annette M. Hartmann,3 Wolfgang Wadsak, Markus Mitterhauser, Dan Rujescu, Siegfried Kasper, and Rupert Lanzenberger
    Translational Psychiatry, January 2019, https://doi.org/10.1038/s41398-018-0308-2 
  32. Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In Vivo
    Gregory M James, Gregor Gryglewski, Thomas Vanicek, Neydher Berroterán-Infante, Cécile Philippe, Alexander Kautzky, Lukas Nics, Chrysoula Vraka, Godber M Godbersen, Jakob Unterholzner, Helen L Sigurdardottir, Marie Spies, René Seiger, Georg S Kranz, Andreas Hahn, Markus Mitterhauser, Wolfgang Wadsak, Andreas Bauer, Marcus Hacker, Siegfried Kasper, and Rupert Lanzenberger
    Cerebral Cortex, January 2019, https://doi.org/10.1093/cercor/bhy249

2018

  1. Microfluidic 68Ga-labeling: a proof of principle study.
    Sarah Pfaff, Cecile Philippe, Verena Pichler, Marcus Hacker, Markus Mitterhauser and Wolfgang Wadsak
    Dalton Transactions, May 2018, https://doi.org/10.1039/c8dt00158h
  2. Probing the association between serotonin-1A autoreceptor binding and amygdala reactivity in healthy volunteers
    Georg S. Kranz, Andreas Hahn, Christoph Kraus, Marie Spies, Verena Pichler, Johannes Jungwirth, Markus Mitterhauser, Wolfgang Wadsak, Christian Windischberger, Siegfried Kasper, Rupert Lanzenberger
    NeuroImage, 2018, https://doi.org/10.1016/j.neuroimage.2017.12.092
  3. EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
    Thorsten D. Poeppel, Daria Handkiewicz-Junak, Michael Andreeff, Alexander Becherer, Andreas Bockisch, Eva Fricke, Lilli Geworski, Alexander Heinzel, Bernd J. Krause, Thomas Krause, Markus Mitterhauser, Wilfried Sonnenschein, Lisa Bodei, Roberto C. Delgado-Bolton, Michael Gabriel
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, https://doi.org/10.1007/s00259-017-3900-4
  4. Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
    Marie Spies, Gregory M James, Neydher Berroterán-Infante, Harald Ibeschitz, Georg S Kranz, Jakob Unterholzner, Mathis Godbersen, Gregor Gryglewski, Marius Hienert, Johannes Jungwirth, Verena Pichler, Birgit Reiter, Leo Silberbauer, Dietmar Winkler, Markus Mitterhauser, Thomas Stimpfl, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger,
    International Journal of Neuropsychopharmacology, 2018, https://doi.org/10.1093/ijnp/pyx085
  5. Comparison of statistical analysis methods for object case best-worst scaling
    Kei Long Cheung, Susanne Mayer, Judit Simon, Hein de Vries, Silvia M.A.A. Evers, Ingrid E.H. Kremer, and Mickaël Hiligsmann
    Journal of Medical Economics, 2018, https://doi.org/10.1080/13696998.2018.1553781
  6. L-[S-methyl-11C]methionine – An example of radiosynthetic optimization
    Verena Pichler, Chrysoula Vraka, Neydher Berroterán-Infante, Andreas Krcal, Harald Eidherr, Tatjana Traub-Weidinger, Marcus Hacker, Markus Mitterhauser, and Wolfgang Wadsak
    Applied Radiation and Isotopes, 2018, https://doi.org/10.1016/j.apradiso.2018.08.021
  7. EGFR is required for FOS-dependent bone tumor development via RSK2/CREB signaling
    Markus Linder, Elisabeth Glitzner, Sriram Srivatsa, Latifa Bakiri, Kazuhiko Matsuoka, Parastoo Shahrouzi, Monika Dumanic, Philipp Novoszel, Thomas Mohr, Oliver Langer, Thomas Wanek, Markus Mitterhauser, Erwin F Wagner, and Maria Sibilia
    EMBO Molecular Medicine, 2018, https://doi.org/10.15252/emmm.201809408
  8. Reduced task durations in functional PET imaging with [18F]FDG approaching that of functional MRI
    Lucas Rischka, Gregor Gryglewski, Sarah Pfaff, Thomas Vanicek, Marius Hienert, Manfred Klöbl, Markus Hartenbach, Alexander Haug, Wolfgang Wadsak, Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger, and Andreas Hahn
    NeuroImage, 2018, https://doi.org/10.1016/j.neuroimage.2018.06.079
  9. Molar activity – The keystone in 11C-radiochemistry: An explorative study using the gas phase method
    Verena Pichler, Thomas Zenz, Cécile Philippe, Chrysoula Vraka, Neydher Berrotéran-Infante, Sarah Pfaff, Lukas Nics, Marius Ozenil, Oliver Langer, Matthäus Willeit, Tatjana Traub-Weidinger, Rupert Lanzenberger, Markus Mitterhauser, Marcus Hacker, and Wolfgang Wadsak
    Nuclear Medicine and Biology, 2018, https://doi.org/10.1016/j.nucmedbio.2018.09.003
  10. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy
    Marie Spies, Gregory M. James, Chrysoula Vraka, Cécile Philippe, Marius Hienert, Gregor Gryglewski, Arkadiusz Komorowski, Alexander Kautzky, Leo Silberbauer, Verena Pichler, Georg S. Kranz, Lukas Nics, Theresa Balber, Pia Baldinger-Melich, Thomas Vanicek, Benjamin Spurny, Edda Winkler-Pjrek, Wolfgang Wadsak, Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger, and Dietmar Winkler
    Translational Psychiatry, 2018, https://doi.org/10.1038/s41398-018-0227-2
  11. PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical Impact
    Bernhard Grubmüller, Pascal Baltzer, Sabrina Hartenbach, David D’Andrea, Thomas H. Helbich, Alexander R. Haug, Gregor M. Goldner, Wolfgang Wadsak, Sarah Pfaff, Markus Mitterhauser, Theresa Balber, Neydher Berroterán-Infante, Marko Grahovac, John Babich, Christian Seitz, Gero Kramer, Martin Susani, Peter Mazal, Lukas Kenner, Shahrokh F. Shariat, Marcus Hacker, and Markus Hartenbach
    Clinical Cancer Research, 2018, https://doi.org/10.1158/1078-0432.CCR-18-0768
  12. Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging
    Gregor Gryglewski, René Seiger, Gregory Miles James, Godber Mathis Godbersen, Arkadiusz Komorowski, Jakob Unterholzner, Paul Michenthaler, Andreas Hahn, Wolfgang Wadsak, Markus Mitterhauser, Siegfried Kasper,  and Rupert Lanzenberger
    NeuroImage, 2018, https://doi.org/10.1016/j.neuroimage.2018.04.068
  13. SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18F]FE@SNAP and [11C]SNAP-7941
    Cécile Philippe, Markus Zeilinger, Monika Dumanic, Florian Pichler, Lukas Fetty, Chrysoula Vraka, Theresa Balber, Wolfgang Wadsak, Katharina Pallitsch, Helmut Spreitzer, Rupert Lanzenberger, Marcus Hacker, and Markus Mitterhauser 
    Molecular Imaging and Biology, 2018, https://doi.org/10.1007/s11307-018-1212-0
  14. Glioma Survival Prediction with Combined Analysis of In Vivo 11C-MET PET Features, Ex Vivo Features, and Patient Features by Supervised Machine Learning
    László Papp, Nina Pötsch, Marko Grahovac, Victor Schmidbauer, Adelheid Woehrer, Matthias Preusser, Markus Mitterhauser, Barbara Kiesel, Wolfgang Wadsak, Thomas Beyer, Marcus Hacker, and Tatjana Traub-Weidinger
    Journal of Nuclear Medicine, 2018, https://doi.org/10.2967/jnumed.117.202267
  15. Preclinical In Vitro and In Vivo Evaluation of [18F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer
    Theresa Balber, Josef Singer, Neydher Berroterán-Infante, Monika Dumanic, Lukas Fetty, Judit Fazekas-Singer, Chrysoula Vraka, Lukas Nics, Michael Bergmann, Katharina Pallitsch, Helmut Spreitzer, Wolfgang Wadsak,    Marcus Hacker, Erika Jensen-Jarolim, Helmut Viernstein,  and Markus Mitterhauser
    Contrast Media & Molecular Imaging, 2018, https://doi.org/10.1155/2018/1269830
  16. Comparison of fully-automated radiosyntheses of [11C]erlotinib for preclinical and clinical use starting from in target produced [11C]CO2 or [11C]CH4
    Cécile Philippe, Severin Mairinger, Verena Pichler, Johann Stanek, Lukas Nics, Markus Mitterhauser, Marcus Hacker, Thomas Wanek, Oliver Langer, and Wolfgang Wadsak
    EJNMMI Radiopharmacy and Chemistry, 2018, https://doi.org/10.1186/s41181-018-0044-1
  17. A new method measuring the interaction of radiotracers with the human P-glycoprotein (P-gp) transporter
    Chrysoula Vraka, Monika Dumanic, Teresa Racz, Florian Pichler, Cecile Philippe, Theresa Balber, Eva-Maria Klebermass, Karl-Heinz Wagner, Marcus Hacker, Wolfgang Wadsak, Markus Mitterhauser
    Nuclear Medicine and Biology, 2018, https://doi.org/10.1016/j.nucmedbio.2018.02.002
  18. [18F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer
    Neydher Berroterán-Infante, Theresa Balber, Petra Fürlinger, Michael Bergmann, Rupert Lanzenberger, Marcus Hacker, Markus Mitterhauser, and Wolfgang Wadsak
    ACS Med. Chem. Lett., 2018, https://doi.org/10.1021/acsmedchemlett.7b00367
  19. Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice
    Ursula J. Lemberger, Claudia D. Fuchs, Christian Schöfer, Andrea Bileck, Christopher Gerner, Tatjana Stojakovic, Makoto M. Taketo, Michael Trauner, Gerda Egger and Christoph H. Österreicher
    Oncotarget, 2018, https://doi.org/10.18632/oncotarget.24346
  20. An Overview of PET Radiochemistry, Part 2: Radiometals
    Marie Brandt, Jens Cardinale, Margaret L. Aulsebrook, Gilles Gasser, and Thomas L. Mindt
    Journal of Nuclear Medicine, 2018, http://jnm.snmjournals.org/content/59/10/1500.full.pdf+html
  21. An Overview of PET Radiochemistry, Part 1: The Covalent Labels 18F, 11C, and 13N
    Verena Pichler, Neydher Berroteran-Infante, Cecile Philippe, Chrysoula Vraka, Eva-Maria Klebermass, Theresa Balber, Sarah Pfaff, Lukas Nics, Markus Mitterhauser, and Wolfgang Wadsak
    Journal of Nuclear Medicine, 2018, http://jnm.snmjournals.org/content/59/9/1350
  22. Economic analysis of biomarker-based anti-EGFR therapies in metastatic colorectal cancer in the Austrian context
    Dora Niedersüß-Beke, Judit Simon, Michael Schiffinger, Robert M. Made
    Magazine of european medical oncology, 2018, https://doi.org/10.1007/s12254-018-0440-y
  23. Development and evaluation of a rapid analysis for HEPES determination in 68Ga-radiotracers
    Sarah Pfaff, Tina Nehring, Verena Pichler, Jens Cardinale, Markus Mitterhauser, Marcus Hacker and Wolfgang Wadsak
    EJNMMI Research 2018, https://doi.org/10.1186/s13550-018-0449-6

2017

  1. Speed matters to raise molar radioactivity: Fast HPLC shortens the quality control of C-11 PET-tracers
    Lukas Nics, Britta Steiner, Eva-Maria Klebermass, Cecile Philippe, Markus Mitterhauser , Marcus Hacker, Wolfgang Wadsak
    Nuclear Medicine and Biology, 2017, https://doi.org/10.1016/j.nucmedbio.2017.11.006
  2. Impact of hybrid PET/MR technology on multiparametric imaging and treatment response assessment of cervix cancer
    Michaela Daniel, Piotr Andrzejewski, Alina Sturdza, Katarina Majercakova, Pascal Baltzer, Katja Pinker, Wolfgang Wadsak, Markus Mitterhauser, Richard Pötter, Petra Georg, Thomas Helbich, Dietmar Georg
    Radiotherapy and Oncology, 2017, https://doi.org/10.1016/j.radonc.2017.10.036
  3. Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials
    Judit Fazekas-Singer, Neydher Berroterán-Infante, Christina Rami-Mark, Monika Dumanic, Miroslawa Matz, Michael Willmann, Fritz Andreae, Josef Singer,Wolfgang Wadsak, Markus Mitterhauser, and Erika Jensen-Jarolim
    Oncotarget, 2017, https://doi.org/10.18632/oncotarget.20914
  4. Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity
    Andreas Hahn, Gregor Gryglewski, Lukas Nics, Lucas Rischka, Sebastian Ganger, Helen Sigurdardottir, Chrysoula Vraka, Leo Silberbauer, Thomas Vanicek, Alexander Kautzky, Wolfgang Wadsak, Markus Mitterhauser, Markus Hartenbach, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger
    Brain Structure and Function, 2017, https://doi.org/10.1007/s00429-017-1558-0
  5. Reconsider logP!
    Chrysoula Vraka, Markus Mitterhauser
    Nuclear Medicine and Biology, 2017, https://doi.org/10.1016/j.nucmedbio.2017.08.007
  6. Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas
    Nina Poetsch, Adelheid Woehrer, Johanna Gesperger, Julia Furtner, Alexander R Haug, Dorothee Wilhelm, Georg Widhalm, Georgios Karanikas, Michael Weber, Ivo Rausch, Markus Mitterhauser, Wolfgang Wadsak, Marcus Hacker, Matthias Preusser, Tatjana Traub-Weidinger
    Neuro-Oncology, 2017, https://doi.org/10.1093/neuonc/nox177
  7. [68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques
    Xiang Li, Daniel Heber, Tatjana Leike, Dietrich Beitzke, Xia Lu, Xiaoli Zhang, Yongxiang Wei, Markus Mitterhauser, Wolfgang Wadsak, Saskia Kropf, Hans J. Wester, Christian Loewe, Marcus Hacker, Alexander R. Haug
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, https://doi.org/10.1007/s00259-017-3831-0
  8. In vivo evaluation of radiotracers targeting the melanin-concentrating hormone receptor 1: [11C]SNAP-7941 and [18F]FE@SNAP reveal specific uptake in the ventricular system
    Markus Zeilinger, Monika Dumanic, Florian Pichler, Lubos Budinsky, Wolfgang Wadsak, Katharina Pallitsch, Helmut Spreitzer, Rupert Lanzenberger, Marcus Hacker, Markus Mitterhauser & Cécile Philippe
    Scientific Reports, 2017, https://doi.org/10.1038/s41598-017-08684-6
  9. The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
    A Kautzky, G M James, C Philippe, P Baldinger-Melich, C Kraus, G S Kranz, T Vanicek, G Gryglewski, W Wadsak, M Mitterhauser, D Rujescu, S Kasper & R Lanzenberger
    Translational Psychiatry, 2017, https://doi.org/10.1038/tp.2017.108
  10. Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET
    Petra Georg, Piotr Andrzejewski, Pascal Baltzer, Michaela Daniel, Wolfgang Wadsak, Markus Mitterhauser, Alina Sturdza, Katarina Majercakova, Georgios Karanikas, Richard Pötter, Marcus Hacker, Thomas Helbich, Dietmar Georg, Katja Pinker
    Molecular Imaging and Biology, 2017, https://doi.org/10.1007/s11307-017-1087-5
  11. LogP, a yesterday’s value?
    Chrysoula Vraka, Lukas Nics, Karl-Heinz Wagner, Marcus Hacker, Wolfgang Wadsak, Markus Mitterhauser
    Nuclear Medicine and Biology, 2017, https://doi.org/10.1016/j.nucmedbio.2017.03.003
  12. Expanding LogP: Present possibilities
    Chrysoula Vraka, Sanja Mijailovic, Vanessa Fröhlich, Markus Zeilinger, Eva-Maria Klebermass, Wolfgang Wadsak, Karl-Heinz Wagner, Marcus Hacker, Markus Mitterhauser
    Nuclear Medicine and Biology, 2017, https://doi.org/10.1016/j.nucmedbio.2017.11.007
  13. New approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kinetics
    Markus Zeilinger, Florian Pichler, Lukas Nics, Wolfgang Wadsak, Helmut Spreitzer, Marcus Hacker and Markus Mitterhauser
    EJNMMI Research, 2017, https://doi.org/10.1186/s13550-016-0249-9
  14. Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion
    G. Gryglewski, L. Rischka, C. Philippe, A. Hahn, G.M. James, E. Klebermass, M. Hienert, L. Silberbauer, T. Vanicek, A. Kautzky, N. Berroterán-Infante, L. Nics, T. Traub-Weidinger, M. Mitterhauser, W. Wadsak, M. Hacker, S. Kasper, R. Lanzenberger,
    NeuroImage, 2017, https://doi.org/10.1016/j.neuroimage.2017.01.050
  15. New avenues for targeted therapies and biomarkers in anaplastic large cell lymphoma
    Gerda Egger & Suzanne D Turner
    Epigenomics, 2017, https://doi.org/10.2217/epi-2016-0159
  16. Methoxinine – an alternative stable amino acid substitute for oxidation-sensitive methionine in radiolabelled peptide conjugates
    Nathalie M Grob, Martin Behe, Elisabeth Von Guggenberg, Thomas Mindt
    Journal of Peptide Science, 2017, https://doi.org/10.1002/psc.2948
  17. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
    Danielle J. Vugts, Chris Klaver, Claudia Sewing, Alex J. Poot, Kevin Adamzek, Seraina Huegli, Cristina Mari, Gerard W. M. Visser, Ibai E. Valverde, Gilles Gasser, Thomas L. Mindt, and Guus A. M. S. van Dongen
    Eur J Nucl Med Mol Imaging, 2017, https://doi.org/10.1007/s00259-016-3499-x
  18. A solid phase-assisted approach for the facile synthesis of a highly water-soluble zirconium-89 chelator for radiopharmaceutical development
    Manon Briand, Margaret L. Aulsebrook, Thomas L. Mindt and Gilles Gasser
    Dalton Transactions, 2017, https://doi.org/10.1039/C7DT03639F
  19. Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer
    Jens Cardinale, René Martin, Yvonne Remde, Martin Schäfer, Antje Hienzsch, Sandra Hübner, Anna-Maria Zerges, Heike Marx, Ronny Hesse, Klaus Weber, Rene Smits, Alexander Hoepping, Marco Müller, Oliver C. Neels and Klaus Kopka
    Pharmaceuticals 2017, https://doi.org/10.3390/ph10040077
  20. Consensus nomenclature rules for radiopharmaceutical chemistry — Setting the record straight
    Heinz H. Coenen, Antony D. Gee, Michael Adam, Gunnar Antoni, Cathy S. Cutler, Yasuhisa Fujibayashi, Jae Min Jeong, Robert H. Mach, Thomas L. Mindt, Victor W. Pike, Albert D. Windhorst,
    Nuclear Medicine and Biology, 2017, https://doi.org/10.1016/j.nucmedbio.2017.09.004
  21. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors
    Theodosia Maina, Aikaterini Kaloudi, Ibai E. Valverde, Thomas L. Mindt, Berthold A. Nock
    Nuclear Medicine and Biology, 2017, https://doi.org/10.1016/j.nucmedbio.2017.06.001
  22. Guidance on validation and qualification of processes and operations involving radiopharmaceuticals
    S. Todde, Kolenc Peitl, P. Elsinga, J. Koziorowski, V. Ferrari, E. M. Ocak, O. Hjelstuen, M. Patt, T. L. Mindt, M. Behe
    EJNMMI Radiopharmacy and Chemistry, 2017, https://doi.org/10.1186/s41181-017-0025-9
  23. Costing evidence for health care decision-making in Austria: A systematic review
    Susanne Mayer, Noemi Kiss, Agata Łaszewska, Judit Simon
    PLoS One, 2017, https://doi.org/10.1371/journal.pone.0183116
  24. State estimation for a penicillin fed-batch process combining particle filtering methods with online and time delayed offline measurements
    Julian Kager, Christoph Herwig, Ines Viktoria Stelzer,
    Chemical Engineering Science, 2017, https://doi.org/10.1016/j.ces.2017.11.049
  25. Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria
    Chiara Feig, Kei Long Cheung , Mickaël Hiligsmann, Silvia M. A. A. Evers, Judit Simon & Susanne Mayer
    Expert Review of Pharmacoeconomics & Outcomes Research, 2017, https://doi.org/10.1080/14737167.2017.1375407 

2016

  1. Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions.
    Aristeidis Chiotellis, Filippo Sladojevich, Linjing Mu, Adrienne Müller Herde, Ibai E. Valverde, Vladimir Tolmachev, Roger Schibli, Simon M. Ametameya and Thomas L. Mindt
    Chemical Commununications, May 2016, https://doi.org/10.1039/c6cc01982j
  2. [18F]FE@SNAP—a specific PET tracer for melanin-concentrating hormone receptor 1 imaging?
    Cécile Philippe, Daniela Haeusler, Thomas Scherer, Clemens Fürnsinn, Markus Zeilinger, Wolfgang Wadsak, Karem Shanab, Helmut Spreitzer, Marcus Hacker, and Markus Mitterhauser
    EJNMMI Res., 2016, https://doi.org/10.1186/s13550-016-0186-7
  3. Glycated 99mTc-Tricarbonyl-Labeled Peptide Conjugates for Tumor Targeting by “Click-to-Chelate”
    Karolin Rçmhild, Christiane A. Fischer, and Thomas L. Mindt
    ChemMedChem, 2016, https://doi.org/10.1002/cmdc.201600485
  4. Toward the Optimization of Bombesin-Based Radiotracers for Tumor Targeting
    Ibai E. Valverde, Sandra Vomstein, and Thomas L. Mindt
    J. Med. Chem., 2016, https://doi.org/10.1021/acs.jmedchem.6b00025